CVRx, Inc. (CVRX)
CVRX Stock Price Chart
Explore CVRx, Inc. interactive price chart. Choose custom timeframes to analyze CVRX price movements and trends.
CVRX Company Profile
Discover essential business fundamentals and corporate details for CVRx, Inc. (CVRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Jun 2021
Employees
206.00
Website
https://www.cvrx.comCEO
Kevin Hykes
Description
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
CVRX Financial Timeline
Browse a chronological timeline of CVRx, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.52, while revenue estimate is $15.55m.
Earnings released on 11 May 2026
EPS came in at -$0.50 surpassing the estimated -$0.51 by +1.96%, while revenue for the quarter reached $14.77m , beating expectations by +1.93%.
Earnings released on 12 Feb 2026
EPS came in at -$0.46 falling short of the estimated -$0.42 by -9.52%, while revenue for the quarter reached $16.02m , beating expectations by +1.56%.
Earnings released on 5 Nov 2025
EPS came in at -$0.49 surpassing the estimated -$0.50 by +2.00%, while revenue for the quarter reached $14.69m , missing expectations by -6.73%.
Earnings released on 4 Aug 2025
EPS came in at -$0.57 falling short of the estimated -$0.52 by -9.62%, while revenue for the quarter reached $13.59m , missing expectations by -5.62%.
Earnings released on 8 May 2025
EPS came in at -$0.53 surpassing the estimated -$0.56 by +5.36%, while revenue for the quarter reached $12.35m , missing expectations by -7.33%.
Earnings released on 4 Feb 2025
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%, while revenue for the quarter reached $15.34m , beating expectations by +0.77%.
Earnings released on 29 Oct 2024
EPS came in at -$0.57 falling short of the estimated -$0.45 by -26.67%, while revenue for the quarter reached $13.37m , beating expectations by +1.23%.
Earnings released on 29 Jul 2024
EPS came in at -$0.65 falling short of the estimated -$0.51 by -27.45%, while revenue for the quarter reached $11.81m , beating expectations by +0.14%.
Earnings released on 30 Apr 2024
EPS came in at -$1.04 falling short of the estimated -$0.53 by -96.23%, while revenue for the quarter reached $10.77m , missing expectations by -5.72%.
Earnings released on 25 Jan 2024
EPS came in at -$0.44 surpassing the estimated -$0.55 by +20.00%, while revenue for the quarter reached $11.31m , beating expectations by +1.48%.
Earnings released on 26 Oct 2023
EPS came in at -$0.43 surpassing the estimated -$0.57 by +24.56%, while revenue for the quarter reached $10.51m , beating expectations by +7.04%.
Earnings released on 25 Jul 2023
EPS came in at -$0.56 surpassing the estimated -$0.57 by +1.75%, while revenue for the quarter reached $9.50m , missing expectations by -3.26%.
Earnings released on 27 Apr 2023
EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%, while revenue for the quarter reached $7.98m , missing expectations by -6.90%.
Earnings released on 26 Jan 2023
EPS came in at -$0.51 surpassing the estimated -$0.55 by +7.27%, while revenue for the quarter reached $7.18m , missing expectations by -0.33%.
Earnings released on 1 Nov 2022
EPS came in at -$0.48 surpassing the estimated -$0.56 by +14.29%, while revenue for the quarter reached $6.19m , beating expectations by +8.15%.
Earnings released on 28 Jul 2022
EPS came in at -$0.54 matching the estimated -$0.54, while revenue for the quarter reached $5.03m , beating expectations by +7.10%.
Earnings released on 25 Apr 2022
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $4.08m , beating expectations by +7.58%.
Earnings released on 15 Feb 2022
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%, while revenue for the quarter reached $3.66m , missing expectations by -10.56%.
Earnings released on 4 Nov 2021
EPS came in at -$0.30 surpassing the estimated -$0.38 by +21.05%, while revenue for the quarter reached $3.40m , beating expectations by +3.51%.
Earnings released on 9 Aug 2021
EPS came in at -$48.48 falling short of the estimated -$30.49 by -59.00%, while revenue for the quarter reached $3.12m , beating expectations by +10.30%.
Earnings released on 4 Aug 2021
EPS came in at -$48.48 falling short of the estimated -$21.27 by -127.93%, while revenue for the quarter reached $2.86m , beating expectations by +32.50%.
CVRX Stock Performance
Access detailed CVRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
